Dilated Cardiomyopathy
By N. K. Lakdawala, Jeffery Winterfield, Birgit Funke. Archives of Disease in Childhood, 2007
1,054 citations recorded by the source corpus.
Address for reprints: Dr. Robert Roberts, Chief of Cardiology, MS-F905, The Methodist Hospital, 6535 Fannin Street, Houston, TX 77030 Hypertrophic cardiomyopathy is a heterogeneous disease with autosomal dominant Mendelian inheritance. In 1989, the 1st locus for hypertrophic cardiomyopathy was mapped to cardiac myosin genes located on chromosome 14q1. Soon, several mutations that cosegregated with inheritance of the disease were identified in the f3-myosin heavy chain gene, or MHY7. More than 30 missense mutations and 1 deletion mutation in the /3-myosin heavy chain gene have since been described. Recently, expression of both the mutant /3-myosin heavy chain mRNA and the mutant protein has been shown in the cardiac and skeletal muscles of individuals with hypertrophic cardiomyopathy. Characterization of the clinical features of /3-myosin heavy chain mutations has shown that certain mutations, such as Arg403Gln and Arg7'9Trp mutations, are associated with high rate of sudden cardiac death. In addition to the /3-myosin heavy chain gene, 3 new loci for hypertrophic cardiomyopathy have recently been described, but the candidate genes have not yet been identified. Dilated cardiomyopathy can be inherited as an autosomal dominant, autosomal recessive, and X-linked disease. The familial form of dilated cardiomyopathy comprises approximately 20% of the cases of idiopathic dilated cardiomyopathy Echocardiographic abnormalities such as left ventricular enlargement are present in 10% of asymptomatic relatives. No gene for familial dilated cardiomyopathy has been identified, but linkage studies using polymorphic, short-tandem repeat markers are ongoing. Dilated cardiomyopathy is a common manifestation of Duchenne/Becker muscular dystrophy. Heart failure is a common cause of death in the affected individuals. The gene responsible for this disease is the dystrophin gene located on X chromosome. There have been reports in these patients of several dystrophin-gene deletion mutations, which result in a decrease in the expression of the dystrophin protein in the cardiac and skeletal tissues. X-linked cardiomyopathy, in which the disease is restricted to the heart, has also been linked to the dystrophin gene. Myotonic dystrophy is an autosomal dominant disease that commonly involves the myocardium and the conduction tissue, resulting in conduction defects and heart failure. Sudden cardiac death is the most common cause of mortality in patients with myotonic dystrophy. Recently, the myotonin protein kinase gene located on chromosome 19 was identified as the gene responsible for this disease. Expansion of the number of trinucleotide repeats in the myotonin protein kinase gene results in myotonic dystrophy. Mutations in mitochondrial DNA have been associated with hypertrophic and dilated cardiomyopathy. The inheritance of mitochondrial cardiomyopathy is maternal and the disease is associated with certain systemic disorders. (Texas Heart Institute Journal 1994;21:6-15)
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/cc8584291b627d2133255d30e3fc48b089a21df3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Morales
- D. Hedges
- R. Hershberger
Citations in the corpus
- Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. (2013, neutral): “NONISCHEMIC DILATED CARDIomyopathy is a common heart muscle disease with a prevalence of at least 1 in 2500 adults.(1) It is characterized by left ventricular cavity enlargement and impaired contractility in the absence of significant coronary artery disease.”
- Dilated cardiomyopathy: the complexity of a diverse genetic architecture (2013, background): “2 (4), 306–313 (2009), with permission from Wolters Kluwer Health.”